Dimethyl dihydro-2H-pyran-4,4(3H)-dicarboxylate, 95.0%, 5g

N-(2,5-Dimethoxyphenyl)-4-methylbenzenesulfonamide, 95%, 250mg

3-(Chlorosulfonyl)-4-hydroxybenzoic acid, 95%, 100mg

1-tert-Butyl 4-methyl 3-oxopiperidine-1,4-dicarboxylate, 95.0%, 10g

2-Bromo-4-chloro pyridine, 99.00%, 10g

2-(Piperidin-4-ylmethoxy)benzo[d]oxazole, 98%, 250mg

3-Oxobutyl acetate, 95.0%, 1g

1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM-2-CARBOXYLATE, 98%, 1g

Acide 3-noradamantanecarboxylique, min.99%, pour la synthèse, 1 g, emballage en verre

(S)-1-((5-chloropyridin-3-yl)methyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one, 1mg

2-Amino-5-bromo-3-chlorobenzonitrile, 90.0%, 5g

Methyl 4-fluorothiophene-2-carboxylate, 95.0%, 1g

Bis(4-bromophenyl)sulfane, 98%, 100g